Posted by Michael Wonder on 12 Dec 2017
EMA publishes agenda for 11-14 December CHMP meeting
12 December 2017 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue initial opinions for the following technologies:
- Hydrocortisone
- Stem cell (mesenchymal, human)
- Anagrelide
- Plitidepsin
- Burosumab
- Trastuzumab
- Velmanase alfa
- Semaglutide
- Rucaparib camsylate
